Figure-1 (Image 01)
Cabtreo Gel
Product Images NDC 0187-0006
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cabtreo (NDC 0187-0006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch Health Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-2 (Image 02)
Carton (Image 03)
This is a description of a topical gel called CABTREO. It contains clindamycin phosphate, adapalene, and benzoyl peroxide. The gel is distributed by Bausch Health US, LLC and manufactured by Bausch Health Companies in Canada. It is a product of Canada and is intended for external use only. The gel should be stored in a refrigerator, between 36 and 46 degrees Fahrenheit, and should not be frozen. The gel should be dispensed with a 10-week expiration date and stored at room temperature. It should be kept out of reach of children and should not be used orally, in the eyes, or intravaginally. The recommended dosage and precautions should be followed as indicated in the prescribing information. Each gram of the gel contains specific quantities of clindamycin phosphate, adapalene, and benzoyl peroxide. The gel comes in a 50g container and has a GTIN, serial number, and expiration date laser burned on the packaging.*
Image1 (Image 04)
Image2 (Image 05)
Image3 (Image 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
